Study guide

7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

Key Takeaways Explain This Topic AI

Accepting back and redistributing an unused drug after it has left the pharmacy is unprofessional conduct unless an exception in Utah Code § 58-17b-503 applies (Utah Code § 58-17b-502(1)(e)).

A Utah pharmacist may redistribute a drug returned from a nursing care facility, jail, prison, or state hospital if it was stored under licensed supervision, is in a unit pack or sealed container, and returns to the original dispensing pharmacy.

A drug from a failed delivery may be redistributed if returned by the same carrier within 14 days of shipping and the pharmacist confirms its integrity, and a controlled substance's CSD report must be corrected (R156-17b-608(2)).

Utah's Charitable Prescription Drug Recycling Program excludes controlled substances except buprenorphine for medication-assisted treatment, compounded drugs, and REMS patient-registry drugs.

An eligible Utah recycling pharmacy may charge $0–$10 when accepting and $0–$5 when dispensing a donated drug (R156-17b-901(3)).

Last updated: September 2026

7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

Blueprint item 2.4 covers "returning or reusing drugs." Utah's rules are §§ 58-17b-502(1)(e), 58-17b-503, 58-17b-623 , Part 9 of the Pharmacy Practice Act (§§ 58-17b-901 to -907) , R156-17b-608 and -901 , and the federal disposal rules in 21 CFR Part 1317 .

The general rule

"Except as provided in Section 58-17b-503, accepting back and redistributing any unused drug, or a part of the unused drug, after the unused drug has left the premises of a pharmacy" is unprofessional conduct (§ 58-17b-502(1)(e)). DOPL's fine schedule sets $1,000–$5,000 for a first offense and $10,000 for a subsequent one.

What is prohibited is redistribution , meaning putting the drug back into stock and dispensing it to someone else. A pharmacy may still take a patient's unwanted drug for disposal (§ 58-17b-623; see below). The drug cannot return to inventory unless an exception applies.

The three exceptions (§ 58-17b-503(2))

  • Exception Conditions
  • (a) Charitable recycling Donated and redispensed under Part 9 (below)

(b) Institutional unit-pack returns Prescribed to a patient in a nursing care facility, licensed ICF for people with an intellectual disability, state prison, county jail, or state hospital ; stored under a licensed health care provider's supervision per manufacturer recommendations; in a unit pack (tamper-resistant, nonreusable, single-dose, single-drug package showing lot number and expiration) or the manufacturer's sealed container ; returned to the original dispensing pharmacy ; originally dispensed by a licensed pharmacist or intern; and the return complies with FDA and DEA rules

(c) Failed delivery The pharmacy tried to deliver by USPS, licensed common carrier, or supportive personnel; the same person or carrier returned it; and a pharmacist determines under FDA rules and DOPL rule that it was not adversely affected

For failed deliveries, R156-17b-608(2) requires the pharmacist to verify the drug came back within 14 days of the ship date , use clinical judgment that the drug and its packaging are intact and uncompromised, and, for a controlled substance, correct the CSD report .

Note

Drugs dispensed in ordinary amber vials to community patients, or returned by a patient who has taken them home, fit none of these exceptions. They may be accepted only for disposal .

Consumer drug disposal

Utah: a pharmacy may accept unused prescription drugs for disposal as federal law allows (§ 58-17b-623). Licensees disposing of controlled substances must follow 21 CFR Part 1317 and keep disposal records five years (R156-37-606).

DEA authorized collectors (21 CFR Part 1317): a retail or hospital pharmacy may modify its DEA registration to become a collector. Key requirements:

The collection receptacle is securely fastened to a permanent structure, locked, and has a small opening that allows contents to be added but not removed.

It is placed where employees can see it, in the immediate proximity of where controlled substances are stored.

Only ultimate users put their own drugs in the receptacle. Staff may not count, sort, inventory, or otherwise handle the contents.

Inner liners are waterproof, tamper-evident, tear-resistant, and opaque, with a unique ID number. They are installed and removed by two employees and sealed immediately.

Sealed liners are destroyed on site or transferred for destruction (for example, by a reverse distributor) so that the contents are non-retrievable .

Controlled and non-controlled drugs may be mixed in the receptacle.

Utah's Charitable Prescription Drug Recycling Program (Part 9; R156-17b-901)

The program lets eligible donors and individuals transfer eligible drugs to eligible pharmacies for dispensing to medically indigent individuals .

Element Rule

Eligible donors Nursing care facilities, assisted living facilities, licensed ICFs, manufacturers, wholesale distributors, eligible pharmacies, and physicians' offices. Individuals may donate to an eligible pharmacy, or to a physician's office that is an eligible donor.

Eligible pharmacies Registered with DOPL as eligible, and either a licensed Class A or B pharmacy or operated by a county, county health department (or its contractor), DHHS, or a charitable clinic

Eligible drugs (§ 58-17b-904) In a unit pack or manufacturer's sealed container , or an injectable ; unopened (or a cancer drug in an unopened single-unit dose removed from a multidose package); accepted and dispensed before the beyond-use or manufacturer expiration date ; not adulterated or mislabeled

Excluded Controlled substances , except buprenorphine for opioid use disorder (medication-assisted treatment); compounded drugs ; drugs dispensable only to patients registered with the manufacturer under FDA requirements (R156-17b-901(5))

Recipients A medically indigent individual in Utah with a practitioner's prescription: uninsured without reasonable means to buy the drug, or insured but unable to afford their share

Fees Handling fees of $0–$10 before accepting and $0–$5 before dispensing (R156-17b-901(3))

Pharmacy duties Inspect every drug for eligibility; follow DSCSA; label to show the drug was dispensed under the program; keep written procedures; create a special training program for pharmacists and technicians and keep training records two years

Liability Absent bad faith or gross negligence, participants are not civilly or criminally liable solely for manufacturing, donating, accepting, or dispensing eligible drugs (§ 58-17b-906)

Utah's statute sets no fixed minimum remaining shelf life. The drug just has to be accepted and dispensed before its expiration or beyond-use date. Refrigerated injectables such as sealed insulin pens are not excluded by category.